prostate cancer

Nuclidium raises $99M for copper-based radiopharma pipeline

Nuclidium raised 79 million Swiss francs as the biotech aims to continue the clinical journey of its copper-based diagnostic and therapeutic offering.

James Waldron Jul 10, 2025 5:04am

White arrow on a road pointing to the rising sun

J&J shares survival data on KLK2 bispecific in prostate cancer

Jun 2, 2025 6:40am

Juri inks $210M T-cell engager deal with China biotech

May 27, 2025 6:00am

Biopsies illuminate potential of Candel's prostate cancer drug

May 22, 2025 6:57pm

pile of cash piggy bank money cash dollars bills spend

Pathos AI's $365M series D to fund trial of Novo tumor drug

May 15, 2025 10:20am

MacroGenics pulls plug on ADC after seeing phase 2 survival data

Mar 21, 2025 7:15am